https://www.selleckchem.com/pr....oducts/tucidinostat-
For SLE, PTB risk for no OCS exposure was 24.9%, and it was 39.1% in low- and 61.2% in high-dose trajectory groups. aRR were 1.80 (95% CI 1.34, 2.4 for high and 1.24 (95% CI 0.97, 1.58) for low groups. Only prednisone equivalent dose 20 mg/day after day 139 was associated with increased PTB (adjusted HR 2.54; 95% CI 1.60, 4.03). For asthma, higher OCS doses early in pregnancy, but not later, were associated with increased PTB. For SLE, higher doses early and later in pregnancy were associated with PTB. For asthma, h
Curtir
Comentario
Compartilhar
